These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26179031)

  • 1. TGR5 signaling reduces neuroinflammation during hepatic encephalopathy.
    McMillin M; Frampton G; Tobin R; Dusio G; Smith J; Shin H; Newell-Rogers K; Grant S; DeMorrow S
    J Neurochem; 2015 Nov; 135(3):565-76. PubMed ID: 26179031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice.
    McMillin M; Grant S; Frampton G; Petrescu AD; Williams E; Jefferson B; Thomas A; Brahmaroutu A; DeMorrow S
    J Neuroinflammation; 2019 Apr; 16(1):69. PubMed ID: 30940161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline.
    McMillin M; Frampton G; Thompson M; Galindo C; Standeford H; Whittington E; Alpini G; DeMorrow S
    J Neuroinflammation; 2014 Jul; 11():121. PubMed ID: 25012628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice.
    McMillin M; Grant S; Frampton G; Andry S; Brown A; DeMorrow S
    J Neuroinflammation; 2016 Aug; 13(1):198. PubMed ID: 27561705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice.
    Li Z; Huang J; Wang F; Li W; Wu X; Zhao C; Zhao J; Wei H; Wu Z; Qian M; Sun P; He L; Jin Y; Tang J; Qiu W; Siwko S; Liu M; Luo J; Xiao J
    J Bone Miner Res; 2019 Apr; 34(4):765-776. PubMed ID: 30536462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay.
    Lo SH; Cheng KC; Li YX; Chang CH; Cheng JT; Lee KS
    Drug Des Devel Ther; 2016; 10():2669-76. PubMed ID: 27578964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells.
    Yanguas-Casás N; Barreda-Manso MA; Nieto-Sampedro M; Romero-Ramírez L
    J Cell Physiol; 2017 Aug; 232(8):2231-2245. PubMed ID: 27987324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Promotes Neuroinflammation during Hepatic Encephalopathy in Mice.
    McMillin M; Frampton G; Grant S; Khan S; Diocares J; Petrescu A; Wyatt A; Kain J; Jefferson B; DeMorrow S
    Front Cell Neurosci; 2017; 11():191. PubMed ID: 28725183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly lipophilic 3-epi-betulinic acid derivatives as potent and selective TGR5 agonists with improved cellular efficacy.
    Wang XY; Zhang SY; Li J; Liu HN; Xie X; Nan FJ
    Acta Pharmacol Sin; 2014 Nov; 35(11):1463-72. PubMed ID: 25283506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.
    Sakanaka T; Inoue T; Yorifuji N; Iguchi M; Fujiwara K; Narabayashi K; Kakimoto K; Nouda S; Okada T; Kuramoto T; Ishida K; Abe Y; Takeuchi T; Umegaki E; Akiba Y; Kaunitz JD; Higuchi K
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1(Suppl 1):60-5. PubMed ID: 25827806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Betulinic Acid Derivatives as Potent TGR5 Agonists with Antidiabetic Effects via Humanized TGR5
    Yun Y; Zhang C; Guo S; Liang X; Lan Y; Wang M; Zhuo N; Yin J; Liu H; Gu M; Li J; Xie X; Nan F
    J Med Chem; 2021 Aug; 64(16):12181-12199. PubMed ID: 34406006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural bear bile powder suppresses neuroinflammation in lipopolysaccharide-treated mice via regulating TGR5/AKT/NF-κB signaling pathway.
    Zhu H; Wang G; Bai Y; Tao Y; Wang L; Yang L; Wu H; Huang F; Shi H; Wu X
    J Ethnopharmacol; 2022 May; 289():115063. PubMed ID: 35149130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice.
    McMillin M; Galindo C; Pae HY; Frampton G; Di Patre PL; Quinn M; Whittington E; DeMorrow S
    J Hepatol; 2014 Dec; 61(6):1260-6. PubMed ID: 25046848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1 Exacerbates Acute Liver Failure and Hepatic Encephalopathy Pathology in Mice by Activating Transforming Growth Factor β1.
    Jefferson B; Ali M; Grant S; Frampton G; Ploof M; Andry S; DeMorrow S; McMillin M
    Am J Pathol; 2020 Feb; 190(2):347-357. PubMed ID: 31734229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase IV inhibition potentiates amino acid- and bile acid-induced bicarbonate secretion in rat duodenum.
    Inoue T; Wang JH; Higashiyama M; Rudenkyy S; Higuchi K; Guth PH; Engel E; Kaunitz JD; Akiba Y
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G810-6. PubMed ID: 22821947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
    Genet C; Strehle A; Schmidt C; Boudjelal G; Lobstein A; Schoonjans K; Souchet M; Auwerx J; Saladin R; Wagner A
    J Med Chem; 2010 Jan; 53(1):178-90. PubMed ID: 19911773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling.
    Masyuk TV; Masyuk AI; Lorenzo Pisarello M; Howard BN; Huang BQ; Lee PY; Fung X; Sergienko E; Ardecky RJ; Chung TDY; Pinkerton AB; LaRusso NF
    Hepatology; 2017 Oct; 66(4):1197-1218. PubMed ID: 28543567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals.
    Li Y; Cheng KC; Niu CS; Lo SH; Cheng JT; Niu HS
    Drug Des Devel Ther; 2017; 11():1127-1134. PubMed ID: 28435224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure.
    McMillin M; Frampton G; Quinn M; Ashfaq S; de los Santos M; Grant S; DeMorrow S
    Am J Pathol; 2016 Feb; 186(2):312-23. PubMed ID: 26683664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INT-777 prevents cognitive impairment by activating Takeda G protein-coupled receptor 5 (TGR5) and attenuating neuroinflammation via cAMP/ PKA/ CREB signaling axis in a rat model of sepsis.
    Jin P; Deng S; Tian M; Lenahan C; Wei P; Wang Y; Tan J; Wen H; Zhao F; Gao Y; Gong Y
    Exp Neurol; 2021 Jan; 335():113504. PubMed ID: 33058889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.